How can cachexia be prevented in cancer patients receiving aggressive protocols involving radiation and chemotherapy?

How can cachexia be prevented in cancer patients receiving aggressive protocols involving radiation and chemotherapy?
How can cachexia be prevented in cancer patients receiving aggressive protocols involving radiation and chemotherapy?
Aoyagi, T., Terracina, K. P., Raza, A., Matsubara, H., & Takabe, K. (2015). Cancer cachexia, mechanism, and treatment. World journal of gastrointestinal oncology, 7(4), 17–29. https://doi.org/10.4251/wjgo.v7.i4.17
Auger, C., Knuth, C. M., Abdullahi, A., Samadi, O., Parousis, A., & Jeschke, M. G. (2019). Metformin prevents the pathological browning of subcutaneous white adipose tissue. Molecular metabolism, 29, 12-23. https://doi.org/10.1016/j.molmet.2019.08.011
Cui, W., Bennett, A., Zhang, P. et al. (2016). A non-human primate model of radiation-induced Cachexia. Sci Rep 6, 23612 https://doi.org/10.1038/srep23612
Damrauer, J. S., Stadler, M. E., Acharyya, S., Baldwin, A. S., Couch, M. E., & Guttridge, D. C. (2018). Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia. European journal of translational myology, 28(2), 7590. https://doi.org/10.4081/ejtm.2018.7590
Dev, R., Wong, A., Hui, D., & Bruera, E. (2017, January 15). The Evolving Approach to Management of Cancer Cachexia. Retrieved from https://www.cancernetwork.com/oncology-journal/evolving-approach-management-cancer-cachexia
Gorenc, M., Kozjek, N. R., & Strojan, P. (2015). Malnutrition and Cachexia in patients with head and neck cancer treated with (chemo) radiotherapy. Reports of Practical Oncology & Radiotherapy, 20(4), 249–258. DOI: 10.1016/j.rpor.2015.03.001
Gullett, N. P., Hebbar, G., & Ziegler, T. R. (2010). Update on clinical trials of growth factors and anabolic steroids in Cachexia and wasting. The American journal of clinical nutrition, 91(4), 1143S–1147S. https://doi.org/10.3945/ajcn.2010.28608E
Joppa, M., Gogas, K., Foster, A., & Markison, S. (2007). Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP (83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice. Peptides, 28(3), 636–642. DOI: 10.1016/j.peptides.2006.11.021
Tisdale, M. (2002). Z Cachexia in cancer patients. Nat Rev Cancer 2, 862–871 https://doi.org/10.1038/nrc927
Yeh, S. S., & Schuster, M. W. (2006). Megestrol acetate in Cachexia and anorexia. International journal of nanomedicine, 1(4), 411–416. DOI: 10.2147/nano.2006.1.4.411

The post How can cachexia be prevented in cancer patients receiving aggressive protocols involving radiation and chemotherapy? appeared first on nursing assignment tutor.